MDLN

Medline
$33.69
−$0.40 (−1.17%)Oct 26, 2026
4.9NeutralMoatMint rating

MoatMint rates Medline (MDLN) 4.9 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 5.9 out of 10.

Return-17.8%5YRange $31.64 - $49.99
$52.2$44.6$37.0$29.4Dec 25May 26Oct 26

Key metrics

The numbers that frame MDLN today
Market cap
$44.29B
Gross margin
26.2%
EV / Sales
1.8
ROIC
5.9%
Div yield
0%
Debt / equity
1.1

MDLN stock rating

How MDLN scores on quality, value, growth, momentum and financial health
4.9out of 10
Neutral overallFair business, fair price
Quality5.9
Growth2.3
Momentum-
Value5.8
Financial Health5.3

Growth

Revenue and earnings trend for MDLN
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about MDLN
Is Medline a good buy?
Hold. Medline has mixed quality. Growth looks poor. That could put pressure on the long-term business case. We think Medline is selling at a fair price.
What is the market capitalization of MDLN?
Medline's market capitalization is $44.29B.
Does MDLN stock pay dividends?
Medline does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MDLN?
Medline's Debt / Equity ratio is 1.09.